The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease

Citation
Kj. O'Byrne et al., The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease, EUR J CANC, 36(2), 2000, pp. 151-169
Citations number
263
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
EUROPEAN JOURNAL OF CANCER
ISSN journal
09598049 → ACNP
Volume
36
Issue
2
Year of publication
2000
Pages
151 - 169
Database
ISI
SICI code
0959-8049(200001)36:2<151:TRBAAT>2.0.ZU;2-7
Abstract
Recent studies have demonstrated that angiogenesis and suppressed cell-medi ated immunity (CMI) play a central role in the pathogenesis of malignant di sease facilitating tumour growth, invasion and metastasis. In the majority of rumours, the malignant process is preceded by a pathological condition o r exposure to an irritant which itself is associated with the induction of angiogenesis and/or suppressed CMI, These include: cigarette smoking, chron ic bronchitis and lung cancer; chronic oesophagitis and oesophageal cancer, chronic viral infections such as human papilloma virus and ano-genital can cers, chronic hepatitis B and C and hepatocellular carcinoma, and Epstein-B arr virus (EV) and lymphomas: chronic inflammatory conditions such as Crohn 's disease and ulcerative colitis and colorectal cancer: asbestos exposure and mesothelioma and excessive sunlight exposure/sunburn and malignant mela noma, Chronic exposure to growth factors (insulin-like grow th factor-1 in acromegaly), mutations in tumour suppressor genes (TP53 in Li Fraumeni synd rome) and long-term exposure to immunosuppressive agents (cyclosporin A) ma y also give rise to similar environments and are associated with the develo pment of a range of solid rumours. The increased blood supply would facilit ate the development and proliferation of an abnormal clone or clones of cel ls arising as the result of: (a) an inherited genetic abnormality; and/or ( b) acquired somatic mutations. the latter due to local production and/or en hanced delivery of carcinogens and mutagenic growth factors, With progressi ve detrimental mutations and growth-induced tumour hypoxia, the transformed cell, to a lesser or greater extent, may amplify the angiogenic process an d CMI suppression. thereby facilitating further tumour growth and metastasi s. There is accumulating evidence that long-term treatment with cyclo-oxyge nase inhibitors (aspirin and indomethacin), cytokines such as interferon-al pha. anti-oestrogens (tamoxifen and raloxifene) and captopril significantly reduces the incidence of solid rumours such as breast and colorectal cance r. These agents are anti-angiogenic and, in the case of aspirin, indomethac in and interferon-alpha have proven immunomodulatory effects. Collectively; these observations indicate that angiogenesis and suppressed CMI play a ce ntral role in the development and progression of malignant disease. (C) 200 0 Elsevier Science Ltd, All rights reserved.